Purpose: To determine the prevalence of age-related maculopathy (ARM) lesio
ns in residents of the slate of Victoria, Australia.
Design: Population-based cross-sectional study.
Participants: Total of 5147 residential and institutionalized persons aged
40 years and older, living in Victoria.
Methods: Participants were recruited through a cluster, stratified, random
sampling from nine urban clusters and four rural clusters. The presence of
ARM lesions was graded from color stereo fundus photographs as well as slit
-lamp stereo biomicroscopy according to the International Classification an
d Grading System.
Main Outcome Measures: The presence of ARM lesions.
Results: The mean age of participants was 60.2 years, and 55% were females.
Gradable fundus photographs were available for at least one eye in 4345 (9
2%) of the participants. The weighted prevalence of neovascular age-related
macular degeneration (AMD) was 0.39% (95% confidence limits [CL] = 0.20, 0
.58), atrophic AMD was 0.27% (95% CL = 0.04, 0.50), and total AMD was 0.68%
(95% CL = 0.30, 1.1). Prevalence of AMD was strongly related to age (P < 0
.001). Prevalence of early ARM was 15.1% (95% CL = 13.7, 16.4). Large druse
n, 125 mu m or more, were present in 6.3% of the participants. There was a
higher prevalence of soft distinct drusen (7.5%) than soft indistinct druse
n (4.3%). Retinal pigmentary abnormalities were present in 8.2% (95% CL = 7
.2, 9.2). The prevalence of large drusen, soft drusen, and pigmentary abnor
malities increased with age (P < 0.001). Prevalence of retinal pigmentary a
bnormalities increased with increasing drusen size (P < 0.001). Soft indist
inct drusen were more common in women aged 70 years or older (P < 0.001). B
ilaterality of any ARM was strongly age related, and women appeared to have
a higher risk of both bilateral early ARM and AMD.
Conclusions: These data provide age- and gender-specific prevalence of ARM
and its component lesions in an ethnically diverse Australian population. E
arly ARM and AMD prevalence rates increased sharply from ages 70 and 80 yea
rs, respectively, in all ethnic groups. These higher rates will continue to
increase the importance of AMD as our population ages. Ophthalmology 2000;
107:1593-1600 (C) 2000 by the American Academy of Ophthalmology.